Table 1.
Demographic and clinical profile of the children with infection-associated KD
| Patient characteristics (number) | N = 10 |
|---|---|
| Age (months, median; IQR) | 57; 24–108 |
| Gender (male:female) | 8:2 |
| Duration of fever [days, (median; IQR)] | 5; 5–6 |
| Rash (number of patients, %) | 4; 40 |
| Mucositis (number of patients, %) | 8; 80 |
| Lymphadenopathy (number of patients, %) | 3; 30 |
| Eye redness (number of patients, %) | 9; 90 |
| Desquamation of the skin (number of patients, %) | 8; 80 |
| Extremity edema (number of patients, %) | 8; 80 |
| Infectious etiology | N = 10 |
|---|---|
| Staphylococcus aureus | 2 |
| Rickettsial (scrub typhus) | 1 |
| Brucella + tuberculosis | 1 |
|
Dengue + chikungunya + staphylococcus (coinfection) |
1 |
| Hepatitis A | 1 |
| COVID-19 (RT-PCR+) | 1 |
| Pseudomonas | 1 |
| Typhoid | 1 |
| Dengue | 1 |
COVID-19 Coronavirus disease 2019; IQR Interquartile range; KD Kawasaki disease; RT-PCR Reverse-transcription polymerase chain reaction